At 5 February 2019, the European Hematology Association and the HARMONY Alliance are organizing the 2nd EHA-HARMONY KOL meeting. The objective of this meeting is to discuss the results of current projects, talk about the newly proposed projects and align on the outcome definition initiative of WP2. Invited to this meeting are the HARMONY Key Opinion Leaders of the 7 Hematological Malignancies Disease Groups.
HARMONY focusses on Acute lymphoblastic leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes, Non-Hodgkins Lymphoma, Multiple Myeloma and Pediatric Hematologic Malignancies. Read more about each of the 7 diseases >.
The HARMONY KOLs are all partners of the HARMONY Alliance.
Receive the latest news. Click here to subscribe!